Correlations Between TET2 Mutation and Clinicohematologic Parameters in Myeloproliferative Neoplasms

被引：0
|
作者：
Ha, Jung Sook [1 ]
Lee, Jae Hee [1 ]
Park, Sung Gyun [1 ]
Ryoo, Nam Hee [1 ]
Jeon, Dong Suk [2 ]
Kim, Jae Ryong [2 ]
Do, Young Rok [3 ]
Kim, Jin Young [4 ]
Kwon, Ki Young [5 ]
Kim, Ji Yoon [6 ]
Suh, Jang Soo [7 ]
机构：
[1] Keimyung Univ, Sch Med, Dept Lab Med, Taegu, South Korea
[2] Keimyung Univ, Sch Medice, Dept Lab Med, Taegu, South Korea
[3] Keimyung Univ, Sch Med, Dept Internal Med, Div Hematol Oncol, Taegu, South Korea
[4] Keimyung Univ, Dongsan Med Ctr, Dept Internal Med, Div Hemato Oncol, Taegu, South Korea
[5] Keimyung Univ, Sch Medine, Dept Internal Med, Div Hematol Oncol, Taegu, South Korea
[6] Keimyung Univ, Sch Medice, Dept Pediat Hematol Oncol, Taegu, South Korea
[7] Kyungpook Natl Univ Hosp, Taegu, South Korea
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.1455.1455
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1455
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Evaluation of allelic strength of human TET2 mutations and cooperation between Tet2 knockdown and oncogenic Nras mutation
    Chang, Yuan-I
    Damnernsawad, Alisa
    Allen, Laura K.
    Yang, David
    Ranheim, Erik A.
    Young, Ken H.
    Zhang, Jingfang
    Kong, Guangyao
    Wang, Jinyong
    Liu, Yangang
    Fu, Hsu-Yuan
    Yang, Chii-Shen
    Guo, Junjie
    Song, Hongjun
    Zhang, Jing
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 166 (03) : 461 - 465
  • [22] Frequent TET2 Mutations in Histiocytic Neoplasms
    Liu, Ying
    Petrova-Drus, Kseniya
    Durham, Benjamin
    Baik, Jeeyeon
    Sigler, Allison
    Rampal, Raajit
    Abdel-Wahab, Omar
    Diamond, Eli
    Dogan, Ahmet
    Yabe, Mariko
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1340 - 1341
  • [23] Frequent TET2 Mutations in Histiocytic Neoplasms
    Liu, Ying
    Petrova-Drus, Kseniya
    Durham, Benjamin
    Baik, Jeeyeon
    Sigler, Allison
    Rampal, Raajit
    Abdel-Wahab, Omar
    Diamond, Eli
    Dogan, Ahmet
    Yabe, Mariko
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1340 - 1341
  • [24] Mutation in TET2 in Myeloid Cancers
    Delhommeau, Francois
    Dupont, Sabrina
    Della Valle, Veronique
    James, Chloe
    Trannoy, Severine
    Masse, Aline
    Kosmider, Olivier
    Le Couedic, Jean-Pierre
    Robert, Fabienne
    Alberdi, Antonio
    Lecluse, Yann
    Plo, Isabelle
    Dreyfus, Francois J.
    Marzac, Christophe
    Casadevall, Nicole
    Lacombe, Catherine
    Romana, Serge P.
    Dessen, Philippe
    Soulier, Jean
    Viguie, Franck
    Fontenay, Michaela
    Vainchenker, William
    Bernard, Olivier A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (22): : 2289 - 2301
  • [25] Mutation in TET2 in Myeloid Cancers
    Tefferi, Ayalew
    Lim, Ken-Hong
    Levine, Ross
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (11): : 1117 - 1117
  • [26] MUTATIONAL ANALYSIS OF TET2 GENE IN BCR-ABL1 NEGATIVE CHRONIC MYELOPROLIFERATIVE NEOPLASMS
    Euba, B.
    Aranaz, P.
    Garcia-Barchino, M. J.
    Hurtado, C.
    Calasanz, M. J.
    Novo, J.
    Vizmanos, J. L.
    Garcia-Delgado, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 597 - 598
  • [27] Loss of TET2 has dual roles in murine myeloproliferative neoplasms: disease sustainer and disease accelerator
    Kameda, Takuro
    Shide, Kotaro
    Yamaji, Takumi
    Kamiunten, Ayako
    Sekine, Masaaki
    Taniguchi, Yasuhiro
    Hidaka, Tomonori
    Kubuki, Yoko
    Shimoda, Haruko
    Marutsuka, Kousuke
    Sashida, Goro
    Aoyama, Kazumasa
    Yoshimitsu, Makoto
    Harada, Taku
    Abe, Hiroo
    Miike, Tadashi
    Iwakiri, Hisayoshi
    Tahara, Yoshihiro
    Sueta, Mitsue
    Yamamoto, Shojiro
    Hasuike, Satoru
    Nagate, Kenji
    Iwama, Atsushi
    Kitanaka, Akira
    Shimoda, Kazuya
    BLOOD, 2015, 125 (02) : 304 - 315
  • [28] Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms
    Jankowska, Anna M.
    Szpurka, Hadrian
    Tiu, Ramon V.
    Makishima, Hideki
    Afable, Manuel
    Huh, Jungwon
    O'Keefe, Christine L.
    Ganetzky, Rebecca
    McDevitt, Michael A.
    Maciejewski, Jaroslaw P.
    BLOOD, 2009, 113 (25) : 6403 - 6410
  • [29] Dangerous Liaisons between Tet2 Mutation, Inflammatory Monocytes, and Leukemogenesis
    Pietras, Eric M.
    DeGregori, James
    CANCER DISCOVERY, 2022, 12 (10) : 2234 - 2236
  • [30] LNK mutation studies in blast-phase myeloproliferative neoplasms, and in chronic-phase disease with TET2, IDH, JAK2 or MPL mutations
    A Pardanani
    T Lasho
    C Finke
    S T Oh
    J Gotlib
    A Tefferi
    Leukemia, 2010, 24 : 1713 - 1718
12345